SUTIMLIMAB-JOME vs SUVOREXANT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SUTIMLIMAB-JOME vs SUVOREXANT: Safety Overview
| Metric | SUTIMLIMAB-JOME | SUVOREXANT |
|---|---|---|
| Total FAERS Reports | 209 | 9,413 |
| Deaths Reported | 28 | 219 |
| Death Rate | 13.4% | 2.3% |
| Hospitalizations | 37 | 572 |
| Average Patient Age | 72.1 yrs | 62.6 yrs |
| % Female Patients | 69.9% | 62.4% |
| FDA Approval Date | N/A | Aug 13, 2014 |
| Manufacturer | N/A | Merck Sharp & Dohme LLC |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Prescription |